Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gardner

Showing results (801-810 of 829) with videos related to

Pageof 83
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemiaCody J Peer, Tristan M Sissung, Aerang Kim, et al.
Blood|February 16, 2010
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisPriya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Impact of ABCB1 allelic variants on QTc interval prolongationTristan M Sissung, Erin R Gardner, Richard L Piekarz, et al.
Mayo Clinic Proceedings|March 17, 2018
OB Nest: Reimagining Low-Risk Prenatal CareMarnie J Meylor de Mooij, Rachael L Hodny, Daniel A O'Neil, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Durable protection against SIV challenge by adeno-associated virus delivery of Env-specific antibodiesNatasha M Clark, Nida K Keles, Grace N Hagedorn, et al.
Nature Genetics|October 15, 1998
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsyB A Minassian, J R Lee, J A Herbrick, et al.
Vaccine|May 28, 2011
Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assayLisa D Schlehuber, Iain J McFadyen, Yu Shu, et al.
Global Ecology and Conservation|June 17, 2026
Limestone karst ecology and anthropogenic activities associated with cave-dwelling bats of Southern Shan State, MyanmarMoe Moe Aung, Thura Soe Min Htike, Nang Phyu Phwe, et al.
Trials|March 2, 2018
Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) studyPatricia Healy, Sandra Galvin, Paula R Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaRichard L Piekarz, Robin Frye, Maria Turner, et al.
Pageof 83

Showing results (801-810 of 829) with videos related to

Sort By:
Pageof 83
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemiaCody J Peer, Tristan M Sissung, Aerang Kim, et al.
Blood|February 16, 2010
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisPriya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Impact of ABCB1 allelic variants on QTc interval prolongationTristan M Sissung, Erin R Gardner, Richard L Piekarz, et al.
Mayo Clinic Proceedings|March 17, 2018
OB Nest: Reimagining Low-Risk Prenatal CareMarnie J Meylor de Mooij, Rachael L Hodny, Daniel A O'Neil, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Durable protection against SIV challenge by adeno-associated virus delivery of Env-specific antibodiesNatasha M Clark, Nida K Keles, Grace N Hagedorn, et al.
Nature Genetics|October 15, 1998
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsyB A Minassian, J R Lee, J A Herbrick, et al.
Vaccine|May 28, 2011
Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assayLisa D Schlehuber, Iain J McFadyen, Yu Shu, et al.
Global Ecology and Conservation|June 17, 2026
Limestone karst ecology and anthropogenic activities associated with cave-dwelling bats of Southern Shan State, MyanmarMoe Moe Aung, Thura Soe Min Htike, Nang Phyu Phwe, et al.
Trials|March 2, 2018
Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) studyPatricia Healy, Sandra Galvin, Paula R Williamson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaRichard L Piekarz, Robin Frye, Maria Turner, et al.
Pageof 83